Market Closed -
Other stock markets
|
|
Pre-market 02:04:21 | ||
28.17 EUR | 0.00% | 28.18 | +0.04% |
12-04 | Stock markets down slightly; oil stocks trailing on Mib. | AN |
11-28 | Marshall Wace makes moves on MPS, BPER and OVS. | AN |
Sales 2023 * | 2.28B 2.46B 3.34B | Sales 2024 * | 2.48B 2.67B 3.63B | Capitalization | 6.35B 6.84B 9.3B |
---|---|---|---|---|---|
Net income 2023 * | 178M 192M 261M | Net income 2024 * | 216M 233M 316M | EV / Sales 2023 * | 3,34x |
Net Debt 2023 * | 1.27B 1.37B 1.86B | Net Debt 2024 * | 1.19B 1.28B 1.74B | EV / Sales 2024 * | 3,04x |
P/E ratio 2023 * | 36,2x | P/E ratio 2024 * | 29,9x | Employees | 13,195 |
Yield 2023 * | 1,00% | Yield 2024 * | 1,14% | Free-Float | 57.46% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
1 week | +0.07% | ||
Current month | -1.26% | ||
1 month | +3.95% | ||
3 months | -3.03% | ||
6 months | -19.45% | ||
Current year | +1.26% |
1 week
27.43
28.17

1 month
26.69
29.15

Current year
24.49
36.27

1 year
24.49
36.27

3 years
23.25
47.59

5 years
13.42
47.59

10 years
3.76
47.59

Managers | Title | Age | Since |
---|---|---|---|
Enrico Vita
CEO | Chief Executive Officer | 54 | 2014 |
Gabriele Galli
DFI | Director of Finance/CFO | 54 | 2017 |
Andrea Ciccolini
CTO | Chief Tech/Sci/R&D Officer | - | 2020 |
Members of the board | Title | Age | Since |
---|---|---|---|
Maurizio Costa
BRD | Director/Board Member | 75 | 2007 |
Giovanni Tamburi
BRD | Director/Board Member | 69 | 2013 |
Chairman | 67 | 1987 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
5.31% | 243 M€ | +11.21% | ||
2.54% | 35 M€ | +13.29% | ||
2.50% | 4 M€ | -.--% | ||
2.00% | 244 M€ | +23.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-12-08 | 28.17 | +2.03% | 411,959 |
23-12-07 | 27.61 | -1.25% | 382,711 |
23-12-06 | 27.96 | +0.98% | 822,725 |
23-12-05 | 27.69 | -0.97% | 598,114 |
23-12-04 | 27.96 | -0.67% | 404,464 |
Real-time Borsa Italiana, December 08, 2023 at 11:44 am
More quotes
Amplifon S.p.A. is the leading worldwide distributor of auditory devices. Net sales break down by activity as follows:
- hearing aid sales (87.2%): auditory prostheses and implants (Amplifon, Beter Horen, Miracle Ear and Sonus brands);
- services (12.8%).
At the end of 2022, the group has a network of 9,208 outlets distributed between owned stores (4,496), franchise stores (1,272) and other (3,440; including corners).
Net sales are distributed geographically as follows: Europe/Middle East/Africa (66.9%), Americas (18%), and Asia/Pacific (15.1%).
Calendar
2024-02-28
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
B+
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
28.17EUR
Average target price
31.17EUR
Spread / Average Target
+10.66%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.26% | 6 830 M $ | |
-4.81% | 181 B $ | |
+2.10% | 106 B $ | |
-8.65% | 67 062 M $ | |
+3.29% | 45 194 M $ | |
+33.18% | 40 450 M $ | |
+21.75% | 40 151 M $ | |
+45.42% | 25 322 M $ | |
-8.00% | 24 513 M $ | |
+26.96% | 24 288 M $ |

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition